Overview

Evaluation of Reader Training Processes

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.
Phase:
Phase 4
Details
Lead Sponsor:
Avid Radiopharmaceuticals